Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Revenue

In the year 2024, Ernexa Therapeutics had annual revenue of $582.00K with 755.88% growth. Ernexa Therapeutics had revenue of $1,000.00 in the quarter ending December 31, 2024, a decrease of -94.12%.

• Revenue (ttm): $582.00K
• Revenue Growth: +755.88%
• P/S Ratio: 4.54
• Revenue / Employee: $97,000
• Employees: 6
• Market Cap: 10.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	582.00K	514.00K	755.88%
Dec 31, 2023	68.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.